Your browser doesn't support javascript.
loading
Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.
Habous, Mohamad; Giona, Simone; Tealab, Alaa; Aziz, Mohammed; Williamson, Ben; Nassar, Mohammed; Abdelrahman, Zeyad; Remeah, Abdallah; Abdelkader, Mohamed; Binsaleh, Saleh; Muir, Gordon.
Affiliation
  • Habous M; Urology and Andrology Department, Elaj Medical Centres, Jeddah, Saudi Arabia.
  • Giona S; King's College Hospital, London, UK.
  • Tealab A; Zagazig University, Zagazig, Egypt.
  • Aziz M; Urology Department, Menoufia University, Shibin Al Kawm, Egypt.
  • Williamson B; University Hospitals Birmingham, Birmingham, UK.
  • Nassar M; Urology and Andrology Department, Elaj Medical Centres, Jeddah, Saudi Arabia.
  • Abdelrahman Z; Urology and Andrology Department, Elaj Medical Centres, Jeddah, Saudi Arabia.
  • Remeah A; Urology and Andrology Department, Elaj Medical Centres, Jeddah, Saudi Arabia.
  • Abdelkader M; Urology and Andrology Department, Elaj Medical Centres, Jeddah, Saudi Arabia.
  • Binsaleh S; Division of Urology, Department of Surgery, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Muir G; King's College Hospital, London, UK.
BJU Int ; 122(5): 889-897, 2018 11.
Article in En | MEDLINE | ID: mdl-29772111
ABSTRACT

OBJECTIVES:

To compare serum testosterone response and symptom improvement in men with hypogonadism in response to treatment with clomiphene citrate (CC), human chorionic gonadotropin (hCG), or a combination of both therapies. PATIENTS AND

METHODS:

A total of 282 men with hypogonadism, wishing to preserve their fertility, were randomized to one of three treatment arms CC 50 mg (n = 95); 5000 IU hCG injections twice weekly (n = 94); or a combination of both therapies (CC + hCG; n = 94). All participants had complete medical history and had undergone thorough physical examination, including body mass index (BMI) assessment. Laboratory tests included serum total testosterone and glycated haemoglobin (HbA1c) measurements. Quantitative Androgen Deficiency in the Aging Male (qADAM) questionnaire scores were also recorded. Morning samples of total serum testosterone levels were assessed at three time points baseline, 1 and 3 months.

RESULTS:

Testosterone levels increased at 1 and 3 months in all three groups. The mean baseline testosterone level was 2.31 ± 0.66 nmol/L, BMI was 30.8 ± 6.2 kg/m2 , and qADAM score was 20.5 ± 3.8. Testosterone levels increased in all groups at all time points, with a final mean value of 5.17 ± 1.77 nmol/L (223% increase) with no statistically significant difference among the groups. qADAM scores had increased in all groups at 1 month (CC group 6.36; hCG group 5.08; CC + hCG group 7.26) and at 3 months (CC group 12.73; hCG group 11.82; CC + hCG group 15.13) with a significant difference in intergroup analysis for the CC + hCG group compared with the other two groups (P < 0.01).

CONCLUSIONS:

All three treatments were equally effective in restoring testosterone levels. Single-agent CC is simple, cheap and may be used as treatment for hypogonadism when maintenance of fertility is desired. This approach seems to be as effective as either hCG alone or a combination of hCG and CC.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Clomiphene / Chorionic Gonadotropin / Hypogonadism Type of study: Clinical_trials Limits: Adult / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2018 Type: Article Affiliation country: Saudi Arabia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Clomiphene / Chorionic Gonadotropin / Hypogonadism Type of study: Clinical_trials Limits: Adult / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2018 Type: Article Affiliation country: Saudi Arabia